Translating advances in neuroscience into benefits for patients with mental illness presents
enormous challenges because it involves both the most complex organ, the brain, and its …

Accelerated TMS is an emerging application of Transcranial Magnetic Stimulation (TMS)
aimed to reduce treatment length and improve response time. Extant literature generally …

Objective: Reducing unsuccessful treatment trials could improve depression treatment.
Quantitative EEG (QEEG) may predict treatment response and is being commercially …

Background Current practice for selecting pharmacological and non-pharmacological
antidepressant treatments has yielded low response and remission rates in Major …

Here we review the paradigm-change from one-size-fits-all psychiatry to more personalized-
psychiatry, where we distinguish between 'precision psychiatry'and 'stratified psychiatry' …

Depressed patients often do not respond to the first antidepressant prescribed, resulting in
sequential trials of different medications. Personalised medicine offers a means of reducing …

Currently, the diagnosis of major depressive disorder (MDD) and its subtypes is mainly
based on subjective assessments and self-reported measures. However, objective criteria …

Antidepressants must be taken for weeks before response can be assessed with many
patients not responding to the first medication prescribed. This often results in long delays …

This narrative review brings together the findings regarding the differences in the auditory
event-related potentials (ERPs) between patients with depressive disorder and non …

Background Attention-deficit/hyperactivity disorder is characterized by neurobiological
heterogeneity, possibly explaining why not all patients benefit from a given treatment. As a …